| A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML (R)) for patients with hepatic malignancies | |
| Chen, Xian-Cheng; Yu, Bo; Dong, Jing-Cheng; Gu, Yu-Xiang; Chen, Lei; Wu, Qing-Zhen; Hou, Nan-Ping; Liu, Jun-Xiong; Xu, Jia-Ting; Jin, Rui-Xie | |
| 刊名 | ANTICANCER RESEARCH
 |
| 2007 | |
| 卷号 | 27期号:3B |
| 关键词 | biological anticancer agent cytotropic heterogeneous molecular lipids (CHML) hepatocellular carcinoma liver metastasis |
| ISSN号 | 0250-7005 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5621357 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Chen, Xian-Cheng,Yu, Bo,Dong, Jing-Cheng,et al. A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML (R)) for patients with hepatic malignancies[J]. ANTICANCER RESEARCH,2007,27(3B). |
| APA | Chen, Xian-Cheng.,Yu, Bo.,Dong, Jing-Cheng.,Gu, Yu-Xiang.,Chen, Lei.,...&Wang, Xin Wei.(2007).A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML (R)) for patients with hepatic malignancies.ANTICANCER RESEARCH,27(3B). |
| MLA | Chen, Xian-Cheng,et al."A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML (R)) for patients with hepatic malignancies".ANTICANCER RESEARCH 27.3B(2007). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论